Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,500 | 23,292 | 25,213 | 47,467 | 18,089 |
| Marketable Securities | 58,240 | 62,840 | 29,617 | 29,985 | 20,666 |
| Receivables | 2,459 | 3,214 | 860 | 2,113 | 1,496 |
| Inventories | 11,906 | 9,299 | 5,078 | 1,245 | 1,667 |
| TOTAL | $85,129 | $100,076 | $62,264 | $82,649 | $43,400 |
| Non-Current Assets | |||||
| PPE Net | 35,319 | 29,966 | 26,492 | 25,103 | 25,825 |
| Intangibles | 11,830 | 12,225 | 4,746 | 5,259 | 7,204 |
| Other Non-Current Assets | 548 | 586 | 762 | 479 | 1,180 |
| TOTAL | $47,697 | $42,777 | $32,000 | $30,841 | $34,209 |
| Total Assets | $132,826 | $142,853 | $94,264 | $113,490 | $77,609 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 1,364 | 7,039 | 4,871 |
| Accounts payable and accrued liabilities | 4,789 | 440 | 2,302 | 3,440 | 4,313 |
| Accrued Expenses | 13,036 | 9,279 | 7,040 | 7,159 | 4,998 |
| Other current liabilities | 837 | 1,164 | 1,221 | 1,219 | 1,293 |
| TOTAL | $19,828 | $15,236 | $19,158 | $31,911 | $17,829 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,930 | 24,670 | 23,632 | 18,537 | 20,603 |
| Deferred Revenues | 1,166 | 4,353 | 7,231 | 13,054 | 2,354 |
| Other Non-Current Liabilities | 3,280 | 3,808 | 6,159 | 6,357 | 7,455 |
| TOTAL | $32,553 | $33,112 | $37,864 | $33,310 | $45,905 |
| Total Liabilities | $52,381 | $48,348 | $57,022 | $65,221 | $63,734 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,554 | 32,419 | 32,315 | 25,411 | 17,229 |
| Common Shares | 32 | 32 | 25 | 25 | 17 |
| Retained earnings | -216,174 | -200,429 | -192,133 | -180,239 | -164,956 |
| Other shareholders' equity | 62 | 96 | 15 | 13 | -7 |
| TOTAL | $80,445 | $94,505 | $37,242 | $48,269 | $13,875 |
| Total Liabilities And Equity | $132,826 | $142,853 | $94,264 | $113,490 | $77,609 |